• Caspase-3 Colorimetric Assay Kit: Practical Guide

  2026-09-17

  The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a lysate-based method for measuring DEVD-dependent caspase-3 activity through p-nitroaniline release. It is appropriate for biochemical apoptosis assays and caspase activity measurement, but should not be treated as an in vivo imaging, direct tissue-staining, or stand-alone proof of caspase-3 specificity.

• Linagliptin (BI-1356) and Tau Research

  2026-09-17

  Linagliptin (BI-1356) is a DPP-4 inhibitor, whereas the cited tau study evaluates the NUAK inhibitor WZ4003. The evidence supports a mechanistic distinction: linagliptin should not be treated as a surrogate for WZ4003 in p-tau Ser356 experiments.

• METTL9 and Cross-Kingdom Antifungal Defense

  2026-09-16

  The 2026 Cell Host & Microbe study identifies secreted METTL9 as a catalytic mucosal defense that methylates the Candida albicans zincophore PRA1 and disrupts fungal zinc acquisition. Its combination of proteomic, biochemical, animal-model, and patient-sample evidence expands antifungal biology beyond membrane damage and conventional drug targets.

• Self-Amplifying RNA Vaccines for Influenza

  2026-09-16

  A 2026 study found that self-amplifying RNA vaccines produced stronger and more durable protection against influenza B than conventional nucleoside-modified mRNA in mice, while maintaining dose-sparing activity against influenza A. The work highlights strain- and platform-specific limits of mRNA vaccination and provides a useful framework for evaluating RNA design, antigen expression, and upstream nucleic-acid quality control.

• Dibutyryl-cAMP, Sodium Salt in Astrocyte Reprogramming

  2026-09-15

  Use DBcAMP sodium salt to interrogate how cAMP–PKA signaling influences astrocyte-to-motoneuron conversion, while separating pathway effects from transcription-factor-driven reprogramming. This workflow combines dose-response design, staged neuronal readouts, and practical troubleshooting for reproducible neural assays.

• How Near-Death Tumor Cells Acquire Metastatic States

  2026-09-15

  Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending-death episode can enter stable prometastatic states rather than simply recover from injury. Their study links these PAME cells to PERK–CHOP-mediated ER stress, GLI and NANOG-associated reprogramming, and a cytokine network that recruits highly migratory PIM cells.

• Dual Metabolic Reprogramming in TNBC Ferroptosis

  2026-09-14

  The reference study identifies a previously overlooked trade-off in DHODH-inhibitor therapy: brequinar can sensitize triple-negative breast cancer cells to ferroptosis while simultaneously increasing lipid droplets that reinforce resistance. Its BQR/A922500-loaded metal–polyphenol nanoplatform couples DHODH and GPX4 suppression with DGAT1-directed lipid remodeling, producing validated antitumor activity in cellular and animal models.

• Trichostatin A: Epigenetic Strategy in Cancer

  2026-09-14

  Trichostatin A (TSA) is more than a benchmark HDAC inhibitor: it is a reversible perturbation tool for connecting histone acetylation with proliferation, differentiation, and subtype-aware translational hypotheses. This article outlines how to use TSA rigorously in breast cancer and broader cancer research while avoiding the interpretive traps of one-size-fits-all epigenetic experimentation.

• Asunaprevir (BMS-650032) Assay Guide

  2026-09-13

  A scenario-based guide to using Asunaprevir (BMS-650032), SKU A3195, in antiviral, viability, proliferation, and cytotoxicity workflows. It explains how potency, solubility, storage, genotype coverage, and orthogonal readouts can improve interpretation without confusing biochemical inhibition with cellular toxicity.

• CP-673451: Selective PDGFRα/β Research Workflows

  2026-09-12

  CP-673451 enables receptor-focused studies of PDGFR signaling, PDGF-BB-dependent angiogenesis, and tumor biology without the broad kinase activity of many multitargeted inhibitors. Its strongest use-case differentiation is the combination of target-engagement assays with ATRX-stratified glioma models and xenograft validation.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-09-11

  Build a rapid, two-color workflow for separating viable, apoptotic, and membrane-compromised cells in leukemia and cytotoxicity studies. This practical guide connects Annexin V-Cy5/DAPI readouts with mitochondrial and signaling measurements from Ph+ ALL research while emphasizing controls, gating, and troubleshooting.

• Measuring Drug Responses Beyond Relative Viability

  2026-09-11

  Hannah R. Schwartz’s dissertation shows that relative viability and fractional viability are not interchangeable measures of anticancer drug response: one combines proliferative arrest with death, whereas the other focuses on cell killing. This distinction supports time-resolved, multi-readout in vitro designs that more accurately separate cytostatic effects from cytotoxic effects.

• TSA and Titanium Osseointegration in Osteoporotic Rats

  2026-09-10

  A Scientific Reports study shows that Trichostatin A improves titanium-rod osseointegration in ovariectomized osteoporotic rats by reducing oxidative stress and activating AKT/Nrf2 signaling. Its combination of oxidative-stress cell modeling, pharmacologic pathway inhibition, and implant-level analysis provides a mechanistic framework for evaluating TSA in bone repair research.

• SCUBE3 Targeting Rewires Cancer Signaling and Immunity

  2026-09-10

  The reference study identifies secretory SCUBE3 as a multifunctional driver of tumor survival, therapy resistance, and immune suppression, then develops a neutralizing antibody to block these activities. Its findings support a translational strategy that combines extracellular target inhibition with analysis of oncogenic signaling, DNA repair, and antigen-presentation pathways.

• Ciprofloxacin as a Gene-Transfer Assay Probe

  2026-09-09

  Ciprofloxacin can do more than inhibit bacterial growth: it can help researchers interrogate resistance phenotypes, plasmid biology, and DNA replication inhibition. This article translates Guangdong hospital surveillance findings into a practical, mechanistically informed framework for antimicrobial resistance research.

8111 records 1/541 page Next 12345 下5页 Last page